Morgan Stanley’s Longevity Acquisition Corporation Ordinary Shares LOAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1
Closed 7664
2020
Q4
$0 Buy
+1
New +$11 ﹤0.01% 7216

Morgan Stanley's LOAC Position: Q1 2021 in Review

Morgan Stanley sold out of Longevity Acquisition Corporation Ordinary Shares (LOAC) in Q1 2021, closing a stake of 1 share.

Morgan Stanley first reported a position in LOAC in Q4 2020 and held it in 1 quarter. The position peaked at $0 in Q4 2020. 0 funds tracked by Wall St. Rank hold LOAC as of Q1 2021.

  • Morgan Stanley reported no remaining Longevity Acquisition Corporation Ordinary Shares position as of Q1 2021 after selling out during the quarter.
  • Morgan Stanley sold 1 Longevity Acquisition Corporation Ordinary Shares share in Q1 2021.
  • Morgan Stanley first reported a position in Longevity Acquisition Corporation Ordinary Shares in Q4 2020 and held it in 1 quarter.
  • Morgan Stanley's Longevity Acquisition Corporation Ordinary Shares position peaked at $0 in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Longevity Acquisition Corporation Ordinary Shares as of Q1 2021.

Based on Morgan Stanley's 13F filing for Q1 2021, filed 17 May 2021.